204 related articles for article (PubMed ID: 33207307)
1. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
Li YP; Liu H; Jin ZB
Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
[TBL] [Abstract][Full Text] [Related]
2. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.
Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG
Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143
[TBL] [Abstract][Full Text] [Related]
3. Generation of two human induced pluripotent stem cell lines from patients with biallelic USH2A variants.
Zhu T; Wu S; Sun Z; Wei X; Han X; Zou X; Sui R
Stem Cell Res; 2021 Aug; 55():102502. PubMed ID: 34419747
[TBL] [Abstract][Full Text] [Related]
4. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
[TBL] [Abstract][Full Text] [Related]
5. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
[TBL] [Abstract][Full Text] [Related]
6. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
[TBL] [Abstract][Full Text] [Related]
9. Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling.
Bolinches-Amorós A; León M; Del Buey Furió V; Marfany G; Gonzàlez-Duarte R; Erceg S; Lukovic D
Stem Cell Res; 2019 Jul; 38():101455. PubMed ID: 31082679
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
[TBL] [Abstract][Full Text] [Related]
11. Generation of an erythroid progenitor-derived iPSC line, VRISGi002-A, from a healthy 27-year-old Vietnamese donor under a feeder-free system.
Nhung Nguyen TH; Trinh Tran TT; Luong TH; Nguyen XH
Stem Cell Res; 2022 Jul; 62():102824. PubMed ID: 35679757
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
[TBL] [Abstract][Full Text] [Related]
13. Generation of two human iPSC lines from patients with autosomal dominant retinitis pigmentosa (UCLi014-A) and autosomal recessive Leber congenital amaurosis (UCLi015-A), associated with RDH12 variants.
Sarkar H; Méjécase C; Harding P; Eintracht J; Toualbi L; Cunha DL; Moosajee M
Stem Cell Res; 2021 Jul; 54():102449. PubMed ID: 34216980
[TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
[TBL] [Abstract][Full Text] [Related]
15. Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936.
Toombs J; Panther L; Ornelas L; Liu C; Gomez E; Martín-Ibáñez R; Cox SR; Ritchie SJ; Harris SE; Taylor A; Redmond P; Russ TC; Murphy L; Cooper JD; Burr K; Selvaraj BT; Browne C; Svendsen CN; Cowley SA; Deary IJ; Chandran S; Spires-Jones TL; Sareen D
Stem Cell Res; 2020 Jul; 46():101851. PubMed ID: 32450543
[TBL] [Abstract][Full Text] [Related]
16. SLC7A14 linked to autosomal recessive retinitis pigmentosa.
Jin ZB; Huang XF; Lv JN; Xiang L; Li DQ; Chen J; Huang C; Wu J; Lu F; Qu J
Nat Commun; 2014 Mar; 5():3517. PubMed ID: 24670872
[TBL] [Abstract][Full Text] [Related]
17. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
[TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line (ZJUi007-A) from a 11-year-old patient of Fabry disease.
Zhu Y; Zhang L; Wang G; Zhao J; Hou X; Wu H; Xu Y; Mao J; Liu Z; Zhang J
Stem Cell Res; 2021 Aug; 55():102475. PubMed ID: 34365103
[TBL] [Abstract][Full Text] [Related]
20. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
